<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: BMS Sheds ConvaTec for $4.1 billion</title>
	<atom:link href="http://www.pharmababble.com/bms-sheds-convatec-for-41-billion/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.pharmababble.com/bms-sheds-convatec-for-41-billion/</link>
	<description>Biomedical investment and business development chatter</description>
	<pubDate>Mon, 15 Mar 2010 10:30:38 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Futures Trading</title>
		<link>http://www.pharmababble.com/bms-sheds-convatec-for-41-billion/comment-page-1/#comment-2739</link>
		<dc:creator>Futures Trading</dc:creator>
		<pubDate>Sat, 26 Sep 2009 00:27:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmababble.com/?p=46#comment-2739</guid>
		<description>totally agree with etrade as you got a great post... but you have to be careful with diversification.</description>
		<content:encoded><![CDATA[<p>totally agree with etrade as you got a great post&#8230; but you have to be careful with diversification.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: etrade</title>
		<link>http://www.pharmababble.com/bms-sheds-convatec-for-41-billion/comment-page-1/#comment-2734</link>
		<dc:creator>etrade</dc:creator>
		<pubDate>Thu, 10 Sep 2009 08:24:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmababble.com/?p=46#comment-2734</guid>
		<description>Very informative and a great article. For me, diverting your money into other business is a great move. If it will increase your profit then why not.</description>
		<content:encoded><![CDATA[<p>Very informative and a great article. For me, diverting your money into other business is a great move. If it will increase your profit then why not.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bristol-Myers Squibb To Be Acquired By&#8230; [Insert Name Here]?? &#124; Pharmababble</title>
		<link>http://www.pharmababble.com/bms-sheds-convatec-for-41-billion/comment-page-1/#comment-24</link>
		<dc:creator>Bristol-Myers Squibb To Be Acquired By&#8230; [Insert Name Here]?? &#124; Pharmababble</dc:creator>
		<pubDate>Tue, 06 May 2008 12:37:58 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmababble.com/?p=46#comment-24</guid>
		<description>[...] a previous post, I speculated on reasons for shedding of non-core pharmaceutical assets by BMS. Don&#8217;t read [...]</description>
		<content:encoded><![CDATA[<p>[...] a previous post, I speculated on reasons for shedding of non-core pharmaceutical assets by BMS. Don&#8217;t read [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
